Premorbid adjustment and remission of positive symptoms in first-episode psychosis
- PMID: 9443000
- DOI: 10.1007/BF00539928
Premorbid adjustment and remission of positive symptoms in first-episode psychosis
Abstract
The impact of premorbid social and intellectual functioning in childhood and early adolescence on the developmental course of schizophrenia is not sufficiently understood. In a retrospective case study (93 consecutive in-patients, 43 males and 50 females) of first-episode psychosis occurring in adolescence, the relationship between premorbid adjustment and short-term therapeutic outcome under treatment conditions was examined. All of the patients had a DSM-III-R diagnosis of schizophrenia (n = 56) or schizo-affective disorder (n = 37). The mean age of the patients at the time of the study was 15.8 (SD = 1.0). Premorbid functioning during childhood and early adolescence was assessed by using the Cannon-Spoor et al. Premorbid Adjustment Scale (PAS) and studied with respect to its prognostic relevance for short-term therapeutic outcome (eight weeks) under neuroleptic treatment (350-700 mg Chlorpromazin dose equivalent). Criteria for clinical outcome were obtained from the study by Pearlson et al. (1989) which defines three grades (complete remission, partial remission and no response), according to the degree of positive symptomatology. Statistical analysis was based on nonparametric variance analysis. Patients with complete remission of positive symptoms after eight weeks of therapy had experienced far better premorbid adjustment in early adolescence and in childhood. Diagnosis and gender did not bias this result. Our data suggest that premorbid social functioning is a crucial variable with regard to therapeutic outcome in first-episode psychosis. Previous studies have reported a relation between poor premorbid functioning and negative symptoms. We found premorbid adjustment related to the course of positive symptoms.
Similar articles
-
Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.J Psychiatr Res. 2007 Oct;41(8):659-66. doi: 10.1016/j.jpsychires.2006.05.002. Epub 2006 Jun 23. J Psychiatr Res. 2007. PMID: 16797591 Clinical Trial.
-
Premorbid functioning of patients with first-episode nonaffective psychosis: a comparison of deterioration in academic and social performance, and clinical correlates of Premorbid Adjustment Scale scores.Schizophr Res. 2008 Sep;104(1-3):206-13. doi: 10.1016/j.schres.2008.06.009. Epub 2008 Jul 26. Schizophr Res. 2008. PMID: 18657952 Free PMC article.
-
Early premorbid adjustment as a moderator of the impact of duration of untreated psychosis.Schizophr Res. 2007 Sep;95(1-3):111-4. doi: 10.1016/j.schres.2007.06.007. Epub 2007 Jul 12. Schizophr Res. 2007. PMID: 17628442
-
Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review.Arch Gen Psychiatry. 2005 Sep;62(9):975-83. doi: 10.1001/archpsyc.62.9.975. Arch Gen Psychiatry. 2005. PMID: 16143729
-
[Duration of untreated psychosis: A state-of-the-art review and critical analysis].Encephale. 2016 Aug;42(4):361-6. doi: 10.1016/j.encep.2015.09.007. Epub 2016 May 6. Encephale. 2016. PMID: 27161262 Review. French.
Cited by
-
Remission in schizophrenia: the relationship to baseline symptoms and changes in symptom domains during a one-year study.J Psychopharmacol. 2009 Jun;23(4):436-41. doi: 10.1177/0269881108093883. Epub 2008 Jun 26. J Psychopharmacol. 2009. PMID: 18583442 Free PMC article. Clinical Trial.
-
Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics.Schizophr Bull. 2007 May;33(3):792-6. doi: 10.1093/schbul/sbl015. Epub 2006 Aug 7. Schizophr Bull. 2007. PMID: 16894026 Free PMC article.
-
Neurocognition: clinical and functional outcomes in schizophrenia.Can J Psychiatry. 2014 Jan;59(1):5-12. doi: 10.1177/070674371405900103. Can J Psychiatry. 2014. PMID: 24444318 Free PMC article. Review.
-
Influencing Factors and Predictors of Early Response in Schizophrenia Patients Receiving the Paliperidone Extended-Release Tablets (Paliperidone ER).Psychiatry Investig. 2013 Dec;10(4):407-16. doi: 10.4306/pi.2013.10.4.407. Epub 2013 Dec 16. Psychiatry Investig. 2013. PMID: 24474991 Free PMC article.
-
Association of premorbid adjustment with symptom profile and quality of life in first episode psychosis in a tertiary hospital in tehran, iran.Iran J Psychiatry. 2010 Winter;5(1):23-7. Iran J Psychiatry. 2010. PMID: 22952486 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical